Recent Comments

Comment RSS

Retinitis Pigmentosa News and Research RSS Feed - Retinitis Pigmentosa News and Research

Retinitis pigmentosa (RP) is the name given to a group of inherited eye diseases that affect the retina (the light-sensitive part of the eye). RP causes the breakdown of photoreceptor cells (cells in the retina that detect light). Photoreceptor cells capture and process light helping us to see. As these cells breakdown and die, patients experience progressive vision loss. The most common feature of all forms of RP is a gradual breakdown of rods (retinal cells that detect dim light) and cones (retinal cells that detect light and color). Most forms of RP first cause the breakdown of rod cells. These forms of RP, sometimes called rod-cone dystrophy, usually begin with night blindness. Night blindness is somewhat like the experience normally sighted individuals encounter when entering a dark movie theatre on a bright, sunny day. However, patients with RP cannot adjust well to dark and dimly lit environments.

Study shows gene therapy can restore vision to children with Leber congenital amaurosis

27. October 2009 03:31
Results from a breakthrough study, conducted by researchers at The Children’s Hospital of Philadelphia (CHOP) and the University of Pennsylvania School of Medicine, show that gene therapy has restored significant vision in five children and seven adults who were previously blind. [More]

Posted in: Child Health News | Medical Science News

Tags: , , ,

Electronic eye implant mimics human retina; restores partial vision

22. October 2009 01:11
A 50-year-old New York woman who was diagnosed with a progressive blinding disease at age 13 was implanted with an experimental electronic eye implant that has partially restored her vision. A team led by Dr. Lucian V. Del Priore at NewYork-Presbyterian Hospital/Columbia University Medical Center performed the June 26 surgery -- the first case of its kind in New York. [More]

Retinal prosthesis restores partial vision to people who are totally blind

21. October 2009 00:41
Two experimental treatments, a retinal prosthesis and fetal tissue transplant, restored some vision to people with blinding eye diseases. The findings, presented at Neuroscience 2009, the annual meeting of the Society for Neuroscience and the world's largest source of emerging news on brain science and health, may lead to new treatments for the blind. Researchers also reported that an engineered protein restored vision in an animal model and identified ways to improve stem cell treatments. [More]

Posted in: Medical Condition News

Tags: , , , , , , ,

Human neural stem cells protect cone photoreceptors: StemCells preclinical data

20. October 2009 07:52
StemCells, Inc. announced today new preclinical data showing that its human neural stem cells protect cone photoreceptors (cones) in the eye from progressive degeneration and preserve visual function long term. [More]

Mimetogen Pharmaceuticals completes its equity financing

8. October 2009 04:58
Mimetogen Pharmaceuticals Inc. ("Mimetogen"), a privately held drug development company announced today that it has successfully completed an equity financing, co-led by Boston-based VIMAC Milestone Medica Fund and Montréal-based iNovia Capital. [More]

Research to explore diagnosis and treatment of rare diseases

7. October 2009 03:05
The National Institutes of Health announced today a second phase of the Rare Diseases Clinical Research Network (RDCRN) including funds for 19 research consortia. [More]

Electrically stimulating nerve cells can restore some vision

24. September 2009 01:30
Results: MIT engineers have designed a retinal implant for people who have lost their vision from retinitis pigmentosa or age-related macular degeneration, two of the leading causes of blindness. The retinal prosthesis would help restore some vision by electrically stimulating the nerve cells that normally carry visual input from the retina to the brain. [More]

Posted in: Device / Technology News

Tags: , , ,

Artificial vision enhancers to reach the market by 2011

19. September 2009 00:29
Visually impaired or blind patients with degenerative retina conditions would be very happy if they were able to regain mobility, find their way around, be able to lead an independent life and to recognize faces and read again. These wishes were documented by a survey conducted by a research team ten years ago to find out what patients' expectations of electronic retina prostheses (retina implants) were. [More]

Posted in: Device / Technology News | Medical Science News

Tags: , , , , ,

Subject enrollment in patients with retinitis pigmentosa for Phase 2 clinical study completed by R-Tech Ueno

25. August 2009 04:52
We are pleased to announce that subject enrollment for the phase 2 clinical study of 0.15% UF-021 (generic name; isopropyl unoprostone; active ingredient of Rescula(R) eye-drops) in patients with retinitis pigmentosa has been completed. [More]

Posted in: Drug Trial News

Tags: , ,

Scientists cultivate multiple types of retina cells from human stem cells

25. August 2009 00:45
A team of scientists from the University of Wisconsin-Madison School of Medicine and Public Health has successfully grown multiple types of retina cells from two types of stem cells — suggesting a future in which damaged retinas could be repaired by cells grown from the patient's own skin. [More]

Posted in: Medical Science News

Tags: , , , , , ,

Gene therapy for retinitis pigmentosa

31. July 2009 11:43
An international team of scientists and clinicians from the United States and Saudi Arabia are working to develop gene therapy for treating a rare, hereditary retinal disease. [More]

Saffron could stop blindness and cure eye disease

17. May 2009 22:54
Italian scientists say they have found that saffron may hold the key to stopping vision loss as people age and in treating some eye diseases. [More]

Posted in: Medical Research News

Tags: , , , , ,

Fish oil protects against neurodegenerative diseases

20. April 2009 08:41
Dr. Nicolas Bazan, Director of the Neuroscience Center of Excellence, Boyd Professor, and Ernest C. and Yvette C. Villere Chair of Retinal Degenerative Diseases Research at LSU Health Sciences Center New Orleans, will present new research findings showing that an omega three fatty acid in the diet protects brain cells by preventing the misfolding of a protein resulting from a gene mutation in neurodegenerative diseases like Parkinson's and Huntington's. [More]

Columbia University licenses retinal imaging technology to PCAsso Diagnostics

13. April 2009 21:12
Columbia University Science and Technology Ventures announced that it has signed a worldwide exclusive license agreement with PCAsso Diagnostics, LLC to develop and market a novel imaging technology for diagnosis of vascular leakage disorders of the retina. [More]

Discovery of new gene that causes Leber congenital amaurosis and retinitis pigmentosa

5. March 2009 20:02
The team of Dr. Robert Koenekoop which includes Dr. Irma Lopez from the Research Institute of the MUHC at the Montreal Children's Hospital played a crucial role in the international collaboration that led to the discovery of a new gene that causes Leber congenital amaurosis (LCA) and retinitis pigmentosa (RP), two devastating forms of childhood blindness. [More]
News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.